National Peroxide Reports ₹11 Cr FY26 Profit, Recommends ₹7 Dividend

National Peroxide Ltd has announced its audited financial results for the fiscal year ending March 31, 2026. The company reported revenue of ₹289.71 crore and a profit after tax of ₹11.04 crore for FY26.

Financial Results and Board Actions

National Peroxide Limited's Board of Directors met on April 30, 2026, to review and approve the audited financial results for the fiscal year and the fourth quarter ended March 31, 2026. The company's audited financial results were approved, with statutory auditors issuing an unmodified report. Key financial decisions included recommending a final dividend of ₹7 per equity share for FY26, alongside a commission of ₹0.17 crore to non-executive directors. Both proposals are subject to shareholder approval at the upcoming Annual General Meeting (AGM). Leadership transitions were also approved: Mr. Amit Goriwale will step down as interim CFO & CRO on May 31, 2026, and Mr. Chirag Kothari has been appointed to these roles, effective June 1, 2026.

Key Financials and Decisions

The company reported stronger financial performance for the fiscal year, marked by increased profitability. The proposed dividend reflects confidence in future earnings and aims to reward shareholders. The upcoming change in CFO & CRO signals a transition in the company's financial leadership. This FY26 performance represents growth from FY25, which saw revenue of approximately ₹270 crore and profit after tax of about ₹8 crore, suggesting improved market conditions or operations.

About National Peroxide

National Peroxide, part of the Wadia Group, is a significant player in India's hydrogen peroxide manufacturing sector.

Immediate Implications

Shareholders are set to receive a potential ₹7 per share dividend, pending approval at the Annual General Meeting. Chirag Kothari will assume the roles of Chief Financial Officer (CFO) and Chief Risk Officer (CRO) starting June 1, 2026. The company's FY26 financial figures are now officially confirmed with an unmodified audit opinion.

Dividend Approval Pending

The recommended final dividend of ₹7 per share and the commission of ₹0.17 crore to non-executive directors are contingent on approval by shareholders at the company's Annual General Meeting.

Market Position

National Peroxide operates within the specific hydrogen peroxide market, where there are few directly listed competitors in India. Larger chemical industry players, such as GHCL Ltd, operate with broader product ranges and at a different scale.

FY26 Financial Snapshot

• Revenue from Operations: ₹28,971.14 lakh (₹289.71 crore) for FY26 (Standalone).
• Profit After Tax: ₹1,103.71 lakh (₹11.04 crore) for FY26 (Standalone).
• Revenue from Operations: ₹8,568.29 lakh (₹85.68 crore) for Q4 FY26 (Standalone).
• Profit After Tax: ₹792.86 lakh (₹7.93 crore) for Q4 FY26 (Standalone).

Looking Ahead

Key items to monitor include the outcome of the Annual General Meeting regarding dividend and director commission approvals. Investors will also watch the transition of the CFO & CRO roles. Tracking the company's response to increasing hydrogen peroxide demand will be important, alongside future earnings reports and management commentary on the business outlook.